1-tert-butyl 3-methyl 5-methylpiperidine-1,3-dicarboxylate, 95.0%, 1g

N-BENZYL-3-BROMO-N-ETHYLBENZENESULFONAMIDE, 95.0%, 5g

2,4-Dinitrofluorobenzene [for HPLC Labeling]>99.0%(GC)5g

(S)-2-Amino-3-(7-fluoro-1H-indol-3-yl)propanoic acid, 95%, 1g

8-BROMO-4-METHYLISOQUINOLINE, 95.0%, 250mg

Diquinoxalino[2,3-a:2',3'-c]phenazine, 95%, 250mg

8-methyl-4-(2-phenylbutanoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide, 97.0%, 10g

6-(Prop-2-yn-1-ylamino)nicotinic acid, 95%, 5g

METHYL (S)-2-AMINO-2-(OXETAN-3-YL)ACETATE, 95.0%, 1g

6-Isopropyl-benzothiazol-2-ylamine, 95.0%, 5g

Methyl 4-hydroxy-5-methoxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate, 97%, 100mg

7-(MORPHOLINE-4-CARBONYL)QUINAZOLIN-4(3H)-ONE, 95.0%, 250mg